XML 60 R44.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stockholders' Equity (Tables)
12 Months Ended
Jan. 02, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Stock-Based Compensation Expense
Total stock-based compensation expense included in our Consolidated Statements of Operations was as follows: 
 
 
Year Ended
(In thousands)
 
January 2,
2016
 
January 3,
2015
 
December 28,
2013
Line item:
 
 
 
 
 
 
Cost of products sold
 
$
1,416

 
$
819

 
$
627

Research and development
 
9,141

 
5,176

 
3,916

Selling, general, and administrative
 
6,793

 
6,807

 
4,979

Acquisition related charges
 
4,293

 

 

Total stock-based compensation
 
$
21,643

 
$
12,802

 
$
9,522

Schedule of Share-based Payment Award, Stock Options and Employee Stock Purchase Plan, Valuation Assumptions
The following table summarizes the assumptions used in the valuation of stock option and ESPP compensation for fiscal years 2015, 2014, and 2013:
 
Year Ended
 
January 2,
2016
 
January 3,
2015
 
December 28,
2013
Employee and Director Stock Options
 
 
 
 
 
Expected volatility
43.6% to 47.3%
 
45.4% to 50.4%
 
51.4% to 54.3%
Risk-free interest rate
1.4% to 1.7%
 
1.5% to1.7%
 
0.7% to 1.0%
Expected term (years)
4.08 to 4.75
 
4.1 to 4.7 years
 
4.1 to 4.5 years
Dividend yield
—%
 
—%
 
—%
Employee Stock Purchase Plan
 
 
 
 
 
Weighted average expected volatility
33.6%
 
38.7%
 
48.0%
Weighted average risk-free interest rate
0.12%
 
0.08%
 
0.11%
Expected term (years)
6 months
 
6 months
 
6 months
Dividend yield
—%
 
—%
 
—%
Schedule of Share-based Compensation, Stock Options, Activity
The following table summarizes our stock option activity and related information for the year ended January 2, 2016:
(Shares and aggregate intrinsic value in thousands)
Shares
 
Weighted
average
exercise price
 
Weighted average
remaining
contractual term (years)
 
Aggregate
Intrinsic Value
Balance, January 3, 2015
9,369

 
$
5.45

 
 
 
 
Grants as a result of Acquisition
2,087

 
4.63

 
 
 
 
Granted
2,348

 
5.68

 
 
 
 
Exercised
(1,159
)
 
3.95

 
 
 
 
Forfeited or expired
(1,201
)
 
5.77

 
 
 
 
Balance, January 2, 2016
11,444

 
$
5.46

 
 
 
 
Vested and expected to vest at January 2, 2016
11,444

 
$
5.46

 
4.26
 
$
12,719

Exercisable, January 2, 2016
6,692

 
$
5.32

 
3.26
 
$
8,256

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The following table summarizes the assumptions used in the valuation of stock options and RSUs with a market condition for fiscal years 2015 and 2014. No stock options or RSUs with a market condition were granted in fiscal year 2013:
 
Year Ended
 
January 2,
2016
 
January 3,
2015
Executive stock options with a market condition
 
 
 
Expected volatility
44% to 46%
 
n/a
Risk-free interest rate
1.4%
 
n/a
Expected term (years)
4.5
 
n/a
Dividend yield
—%
 
n/a
Executive RSUs with a market condition
 
 
 
Expected volatility
36.9%
 
53.5%
Risk-free interest rate
0.6%
 
2.2%
Expected term (years)
2.0
 
0.24
Dividend yield
—%
 
—%
Schedule of Nonvested Restricted Stock Units Activity
The following table summarizes our RSU activity for the year ended January 2, 2016:
(Shares in thousands)
Shares
 
Weighted average grant date fair value
Balance at January 3, 2015
2,021

 
$
6.66

Grants as a result of Acquisition
2,025

 
5.37

Granted
3,203

 
5.92

Vested
(1,624
)
 
6.04

Forfeited
(868
)
 
6.02

Balance at January 2, 2016
4,757

 
$
5.95